• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Studies on in vivo evaluation system of treatment for cancer prevention and progression using cancer prone gene-engineered mice

Research Project

Project/Area Number 12558097
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section展開研究
Research Field Laboratory animal science
Research InstitutionCentral Institute for Experimental Animals

Principal Investigator

OHNISHI Yasuyuki  Cent. Inst. Exp. Anim. Lab. Oncology Head, 腫瘍研究室, 室長 (70201382)

Co-Investigator(Kenkyū-buntansha) TAMAOKI Norikazu  Cent. Inst. Exp. Anim. Res. Project Ctr. Vice Director, 副所長 (50055860)
USUI Toshimi  Cent. Inst. Exp. Anim. Carcinogenicity Testing Ctr. Head, 医薬品評価センター, センター長 (10311234)
HIOKI Kyoji  Cent. Inst. Exp. Anim. Lab. Animal Breeding Head, 飼育技術研究室, 室長 (80208735)
OKADA Masaji  Kinki Chuo Hosp. Clinical Res. Ctr. Head, 臨床研究センター, 部長 (40160684)
ARAI Toshiro  Nippon Vet. Zootech. Univ. Dept. Biochem. Prof., 獣医生理化学教室, 助教授 (70184257)
中村 雅登  東海大学, 医学部・病態診断系病理学, 助教授 (00164335)
Project Period (FY) 2000 – 2002
Project Status Completed (Fiscal Year 2002)
Budget Amount *help
¥13,200,000 (Direct Cost: ¥13,200,000)
Fiscal Year 2002: ¥3,000,000 (Direct Cost: ¥3,000,000)
Fiscal Year 2001: ¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2000: ¥6,700,000 (Direct Cost: ¥6,700,000)
KeywordsH-ras / IL-6 / transgenic / knockout / bigenic / cancer prevention / mouse / urethane / トランスジェニツク / 肺がん / ビニルカーバメート / 変異 / ビニールカーバメート / p53 / メチルニトロソウレア
Research Abstract

We studied to establish in vivo evaluation system of treatment for cancer prevention and progression using cancer prone gene-engineered mice. We have been studying carcinogenicity testing model using rasH2 transgenic mice harboring human prototype H-ras oncogene. In this study, we established urethane-induced lung cancer model with very rapid tumorigenicity. We applied this cancer prone mice system for evaluation of drug or treatment protocol for cancer protection or prevention of cancer progression such as chemoprevention.
The rasH2 mice were injected urethane to induce lung tumor. After or before urethane injection, IL-6 related gene complex (IL-6, IL-6 receptor and gp130) was challenged into the mice. The incidence of lung tumor formation in the urethane injected rasH2 mice was clearly reduced, meaning the IL-6 related gene complex has chemoprevention effects.
The mutational analyses of introducing human H-ras were performed in the lung tumor which induced by urethane and vinylcarbamate (VC, proximal carcinogen of urethane). The results showed almost all tumors had mutation at the 61st codon of H-ras. These results suggested that point mutations at codon 61 of the transgene play an important role in the carcinogenesis of VC- and urethane- induced lung tumors in rasH2 mice.

Report

(4 results)
  • 2002 Annual Research Report   Final Research Report Summary
  • 2001 Annual Research Report
  • 2000 Annual Research Report
  • Research Products

    (27 results)

All Other

All Publications (27 results)

  • [Publications] Maruyama, C: "Overexpression of human H-ras transgene is responsible for tumors induced by chemical carcinogens in mice"Oncol.Rep.. 8. 233-237 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Ohnishi, Y.: "Induction of drug metabolism-related enzymes by methylcholanthrene and phenobarbital in transgenic mice carrieng human prototype c-Ha-ras gene and their wild type littermates"Exp.Anim.. 50. 33-39 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Chulan, S.: "Characterization of the mutations of the K-ras, p53, p16, and SMAD4 genes in 15 human pancreatic cancer cell lines"Oncol.Rep.. 8. 89-92 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Suemizu, H.: "Transgene stability and feature of rasH2 mice as an animal model for short-term carcinogenicity testing"Mol.Carcinonenesis. 34. 1-9 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Arai, T.: "Changes in hepatic enzyme activities in transgenic mice carrying human prototype c-Ha-ras gene treated with diethylnitrosamine"J.Vet.Med.Sci.. 64. 1065-1067 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Tomisawa, M.: "Mutation analysis of vinyl carbamate or urethane induced lung tumors in rasH2 transgenic mice"Toxicology Letters. 142. 111-117 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Marujyama, C,: "Overexpression of human H-ras transgene is responsible for tumors induced by chemical carcinogens in mice"Oncol. Rep.,. 8. 223-237 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Yasuyuki Ohnishi: "Induction of drug metabolism-related enzymes by methylchol anthrene and phenobarbital in transgenic mice carrieng human prototype c-Ha-ras gene and their wild type littermates"Exp. Anim.. 50. 33-39 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Chulan, S.a: "Characterization of the mutations of the K-ras, p53, p16, and SMAD4 genes in 15 human pancreatic cancer cell lines"Oncol. Rep.. 58. 89-92 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Sueinizu, H,: "Transgene stability and feature of rasH2 mice as an animal model for short-term carcinogenicity testing"Mol. Carcinonenesis. 34. 1-9 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Aral, T.: "Changes in hepatic enzyme activities in transgenic mice carrying human prototype c-Ha-ras gene treated with diethylnitrosamine"J.Vet. Med Sci.,. 64. 1065-1067 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Tomisawa, M..: "Mutation analysis of vinyl carbamate or urethane induced lung tumors in rasH2 transgenic mice"Toxicology Letters. 142. 111-117 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Tomii, Y.: "Human thrombospondin 2 inhibits proliferation of microvascular endothelial cells"Int.J.Oncol.. 20. 339-342 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Zembutsu H.: "Genome-wide cDNA microarray screening to correlate gene expiession profiles with sensitivity of 85 human cancer xenografts to anticancer drugs"Cancer Res.. 62. 518-527 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Suemizu, H.: "Two-color allele-specific polymerase chain reaction (PCR-SSP) assay of the leptin receptor gene (Leprdb) for genotyping mouse diabetes mutation"Exp.Anim.. 50. 435-439 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] Suemizn, H: "Transgene stability and feature of rasH2 mice as an animal model for short-term carcinogenicity testing"Mol.Carcinonenesis. 34. 1-9 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Arai, T.: "Changes in hepatic enzyme activities in tninsgenic mice carrying human prototype c-Ha-ras gene treated with diethylnitrosamine"J.Vet.Med.Sci.. 64. 1065-167 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Birumachi, J.: "Diesel exhaust-induced airway hyperresponsiveness in c-Ha-ras transgenic mice"Toxicology. 163. 145-152 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] Tomii, Y.: "Human thrombospondin 2 inhibits proliferation of microvascular endothelial cells"Int.J.Oncol. 20. 339-342 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Zembutsu H.: "Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human cancer xenografts to anticancer drugs"Cancer Res.. 62. 518-527 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Suemizu, H.: "Two-color allele-specific polymerase chain reaction (PCR-SSP) assay of the leptin receptor gene (Leprdb) for genotyping mouse diabetes mutation"Exp.Anim. 50. 435-439 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Goto, K.: "Contamination of transplantable human tumor-bearing lines by Helicobacter hepaticus and its elimination"J.Clin.Microbiology. 39. 3703-3704 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Naruke, M.: "Interlcukin-10 expression is correlated with growth fraction in human non-small cell lung cancer xenografts"Int.J.Oncol. 18. 1213-1217 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Birumachi, J.: "Diesel exhaust-induced airway hyperresponsiveness in c-Ha-ras transgenic mice"Toxicology. 163. 145-152 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Maruyama,C: "Overexpression of human H-ras transgene is responsible for tumors induced by chemical carcinogens in mice"Oncol.Rep.. 8. 233-237 (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] Ohnishi,Y.: "Induction of drug metabolism-related enzymes by methylcholanthrene and phenobarbital in transgenic mice carrieng human prototype c-Ha-ras gene and their wild type littermates"Exp.Anim.. 50. 33-39 (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] Chulan,S.: "Characterization of the mutations of the K-ras, p53, p16, and SMAD4 genes in 15 human pancreatic cancer cell lines"Oncol.Rep.. 8. 89-92 (2001)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi